Abstract Details
Steven Z. Rapcsak, MD
PRESENTER |
No disclosure on file |
Katharine A. Nicholson, MD | Dr. Nicholson has received personal compensation for serving as an employee of Sanofi. Dr. Nicholson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Nicholson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Nicholson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Nicholson has stock in Sanofi. The institution of Dr. Nicholson has received research support from Alector LLC. The institution of Dr. Nicholson has received research support from AI Therapeutics. The institution of Dr. Nicholson has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Nicholson has received research support from Biogen. The institution of Dr. Nicholson has received research support from NIH. The institution of Dr. Nicholson has received research support from Muscular Dystrophy Association. The institution of Dr. Nicholson has received research support from ALS Association. The institution of Dr. Nicholson has received research support from ALS Finding a Cure. The institution of Dr. Nicholson has received research support from Target ALS. |
Andrew T. DeMarco, PhD, CCC-SLP (Georgetown University) | No disclosure on file |
Stephen M. Wilson, PhD | No disclosure on file |
No disclosure on file |